Literature DB >> 58844

Mycobacterial antigens in antibody responses of leprosy patients.

G Kronvall, G Bjune, J Stanford, S Menzel, D Samuel.   

Abstract

A reference system for M. smegmatis antigens in crossed immunoelectrophoresis was used to study antibody activities in serum samples of 91 leprosy patients. All polar and borderline lepromatous patients were positive. Mean numbers out of 14 M. smegmatis antigens involved were 4.3 and 3.5, respectively. Precipitins against antigen no. 1 were seen in all lepromatous cases. Antibodies against this antigen were detected in 50% of tuberculoid (polar, subpolar and borderline) cases. Antibody activity against M. avium and M. duvalii antigens was also detected using a staphylococcal radio-immuno-assay. Borderline and polar lepromatous cases showed elevated levels. Antigenic comparisons were made between four slow growing mycobacteria, fourteen fast growing mycobacteria and the leprosy bacillus using lepromatous serum pools as antibody reagents. Four of the antigens detected in M. leprae were also found in slow growing as well as fast growing species indicating a common occurrence among mycobacteria. Antigen no. 1 of M. duvalii, with an apparent molecular weight of 290,000, showed nonprotein characteristics. Further analysis of antigen no. 21, using lepromatous serum pools as antibody reagents, indicated the existence of at least two groups of antigenic determinants. In addition to determinants shared by all mycobacteria, there were antigenic structures apparently unique to M. leprae.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 58844

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  11 in total

Review 1.  Biological, chemical, immunological and staining properties of bacteria isolated from tissues of leprosy patients.

Authors:  C Cocito; J Delville
Journal:  Eur J Epidemiol       Date:  1985-09       Impact factor: 8.082

2.  Production and assay of antibodies against one antigenic component of Mycobacterium bovis BCG.

Authors:  M Harboe; O Closs; K Svindahl; J Deverill
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

3.  Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG.

Authors:  M Harboe; S Nagai; M E Patarroyo; M L Torres; C Ramirez; N Cruz
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

4.  Catalases, peroxidases, and superoxide dismutases in Mycobacterium leprae and other mycobacteria studied by crossed immunoelectrophoresis and polyacrylamide gel electrophoresis.

Authors:  S T Lygren; O Closs; H Bercouvier; L G Wayne
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

5.  Genetic epidemiology of the susceptibility to leprosy.

Authors:  E D Shields; D A Russell; M A Pericak-Vance
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

6.  Immunological relatedness of ribosomes from mycobacteria, nocardiae and corynebacteria, and microorganisms in leprosy lesions.

Authors:  R Laub; J Delville; C Cocito
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

7.  Antibody response in rabbits to immunization with Mycobacterium leprae.

Authors:  M Harboe; O Closs; B Bjorvatn; G Kronvall; N H Axelsen
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

8.  Comparative studies of antigen 21 in Mycobacterium and Nocardia species: possible taxonomic relationships with Mycobacterium leprae.

Authors:  K Widebäck; G Kronvall; B Bjorvatn; O Closs; M Harboe
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

9.  Specific absorption of human serum albumin, immunoglobulin A, and immunoglobulin G with selected strains of group A and G streptococci.

Authors:  G Kronvall; A Simmons; E B Myhre; S Jonsson
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

10.  Common antigen of Mycobacterium leprae, M. lepraemurium, M. avium, and M. fortuitum in comparative studies using two different types of antisera.

Authors:  G Kronvall; O Closs; G Bjune
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.